You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 28, 2024

ZANTAC 300 Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Zantac 300 patents expire, and when can generic versions of Zantac 300 launch?

Zantac 300 is a drug marketed by Glaxosmithkline and Glaxo Grp Ltd and is included in two NDAs.

The generic ingredient in ZANTAC 300 is ranitidine hydrochloride. There are forty-three drug master file entries for this compound. Thirteen suppliers are listed for this compound. Additional details are available on the ranitidine hydrochloride profile page.

Drug patent expirations by year for ZANTAC 300
Recent Clinical Trials for ZANTAC 300

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Spaulding Clinical Research LLCPhase 1
Food and Drug Administration (FDA)Phase 1
Nova Scotia Health AuthorityPhase 4

See all ZANTAC 300 clinical trials

US Patents and Regulatory Information for ZANTAC 300

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Glaxosmithkline ZANTAC 300 ranitidine hydrochloride CAPSULE;ORAL 020095-002 Mar 8, 1994 DISCN Yes No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Glaxo Grp Ltd ZANTAC 300 ranitidine hydrochloride TABLET;ORAL 018703-002 Dec 9, 1985 DISCN Yes No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for ZANTAC 300

International Patents for ZANTAC 300

See the table below for patents covering ZANTAC 300 around the world.

Country Patent Number Title Estimated Expiration
Sweden 8206061 ⤷  Try a Trial
Italy 1237410 COMPRESSA DI CLORIDRATO DI RANITIDINA E PROCEDIMENTO PER PRODURLA ⤷  Try a Trial
Denmark 427182 ⤷  Try a Trial
South Africa 9001348 ⤷  Try a Trial
New Zealand 184759 AMINOALKYL-FURAN DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS ⤷  Try a Trial
Ireland 60723 Film coated ranitidine hydrochloride tablet ⤷  Try a Trial
Sweden 501694 Ranitidin-hydroklorid-tablett belagd med en polymerfilm av hydroxipropylmetylcellulosa och triacetylglykol ⤷  Try a Trial
>Country >Patent Number >Title >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.